Genezen

Indianapolis, United States Founded: 2014 • Age: 12 yrs
CDMO focused on manufacturing of viral vector products
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 6 Brand Intelligence

About Genezen

Genezen is a company based in Indianapolis (United States) founded in 2014. Genezen operates in a competitive market with competitors including VectorBuilder, 3PBiovian, Oxford Biomedica Solutions, Ascend and Yaunxing Gene Technology, among others.

  • Headquarter Indianapolis, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Genezen Phamaceuticals Private Limited
  • Date of Incorporation 10 May, 2011
  • Jurisdiction Thane, Maharashtra, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Genezen

Investors in Genezen

Genezen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
Locked Locked Locked
Premium access

Investor details for Genezen

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Genezen

Investments
Premium access

Investment portfolio details for Genezen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Genezen

Premium access

Detailed financials for Genezen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Genezen Comparisons

Genezen Primary company
Description
CDMO focused on manufacturing of viral vector products
Location
Indianapolis, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Genezen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Genezen

Genezen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VectorBuilder, 3PBiovian, Oxford Biomedica Solutions, Ascend and Yaunxing Gene Technology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Custom vector design, cloning, and virus packaging are offered online.
Locked Locked Locked
CDMO focused on developing viral vectors
Locked Locked Locked
Oxford Biomedica Solutions is a CDMO focused on manufacturing AAV cell and gene therapy products.
Locked Locked Locked
Online insurance payments and premium financing are enabled for businesses.
Locked Locked Locked
Provider of gene therapy drugs and viral vector and mRNA drug CDMO services
Premium access

Detailed competitors of Genezen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Genezen

Premium access

Complete news archive for Genezen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genezen

Genezen was founded in 2014 and raised its 1st funding round 7 years after it was founded.

Genezen is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.

Genezen was founded in 2014 and is headquartered in Indianapolis, United States. Operations are centered in the biotechnology sector, where contract development and manufacturing services for viral vector products are offered. These services support gene therapy applications and related biopharmaceutical needs. Focus is placed on scalable production processes to meet client requirements in the viral vector space.

Genezen's top competitors include VectorBuilder, Ascend and 3PBiovian.

Genezen has 1 investor. Key investors include Ampersand Capital Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available